Literature DB >> 17717153

Cysteine redox sensor in PKGIa enables oxidant-induced activation.

Joseph R Burgoyne1, Melanie Madhani, Friederike Cuello, Rebecca L Charles, Jonathan P Brennan, Ewald Schröder, Darren D Browning, Philip Eaton.   

Abstract

Changes in the concentration of oxidants in cells can regulate biochemical signaling mechanisms that control cell function. We have found that guanosine 3',5'-monophosphate (cGMP)-dependent protein kinase (PKG) functions directly as a redox sensor. The Ialpha isoform, PKGIalpha, formed an interprotein disulfide linking its two subunits in cells exposed to exogenous hydrogen peroxide. This oxidation directly activated the kinase in vitro, and in rat cells and tissues. The affinity of the kinase for substrates it phosphorylates was enhanced by disulfide formation. This oxidation-induced activation represents an alternate mechanism for regulation along with the classical activation involving nitric oxide and cGMP. This mechanism underlies cGMP-independent vasorelaxation in response to oxidants in the cardiovascular system and provides a molecular explantion for how hydrogen peroxide can operate as an endothelium-derived hyperpolarizing factor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17717153     DOI: 10.1126/science.1144318

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  181 in total

Review 1.  The Nox family of NADPH oxidases: friend or foe of the vascular system?

Authors:  Ina Takac; Katrin Schröder; Ralf P Brandes
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

Review 2.  Redox modification of cell signaling in the cardiovascular system.

Authors:  Dan Shao; Shin-ichi Oka; Christopher D Brady; Judith Haendeler; Philip Eaton; Junichi Sadoshima
Journal:  J Mol Cell Cardiol       Date:  2011-09-17       Impact factor: 5.000

3.  cGMP-dependent protein kinase and the regulation of vascular smooth muscle cell gene expression: possible involvement of Elk-1 sumoylation.

Authors:  ChungSik Choi; Hassan Sellak; Felricia M Brown; Thomas M Lincoln
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-08-27       Impact factor: 4.733

Review 4.  cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.

Authors:  Sharron H Francis; Jennifer L Busch; Jackie D Corbin; David Sibley
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

Review 5.  Cysteine oxidative posttranslational modifications: emerging regulation in the cardiovascular system.

Authors:  Heaseung S Chung; Sheng-Bing Wang; Vidya Venkatraman; Christopher I Murray; Jennifer E Van Eyk
Journal:  Circ Res       Date:  2013-01-18       Impact factor: 17.367

Review 6.  Oxidative stress and sarcomeric proteins.

Authors:  Susan F Steinberg
Journal:  Circ Res       Date:  2013-01-18       Impact factor: 17.367

7.  Mechanism of protein decarbonylation.

Authors:  Chi-Ming Wong; Lucia Marcocci; Dividutta Das; Xinhong Wang; Haibei Luo; Makhosazane Zungu-Edmondson; Yuichiro J Suzuki
Journal:  Free Radic Biol Med       Date:  2013-09-14       Impact factor: 7.376

8.  Prevention of PKG-1α Oxidation Suppresses Antihypertrophic/Antifibrotic Effects From PDE5 Inhibition but not sGC Stimulation.

Authors:  Taishi Nakamura; Guangshuo Zhu; Mark J Ranek; Kristen Kokkonen-Simon; Manling Zhang; Grace E Kim; Kenichi Tsujita; David A Kass
Journal:  Circ Heart Fail       Date:  2018-03       Impact factor: 8.790

9.  Prolonged treatment of porcine pulmonary artery with nitric oxide decreases cGMP sensitivity and cGMP-dependent protein kinase specific activity.

Authors:  William J Perkins; David O Warner; Keith A Jones
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-10-24       Impact factor: 5.464

10.  Chronic inhibition of PPAR-γ signaling induces endothelial dysfunction in the juvenile lamb.

Authors:  Shruti Sharma; Jubilee Barton; Ruslan Rafikov; Saurabh Aggarwal; Hsuan-Chang Kuo; Peter E Oishi; Sanjeev A Datar; Jeffrey R Fineman; Stephen M Black
Journal:  Pulm Pharmacol Ther       Date:  2012-12-17       Impact factor: 3.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.